A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn ("line 61") Mice.

Richter, Franziska; Stanojlovic, Milos; Käufer, Christopher; Gericke, Birthe; Feja, Malte

Richter, Franziska; Stanojlovic, Milos; Käufer, Christopher; Gericke, Birthe; Feja, Malte.

Afiliação

Richter F; Department of Pharmacology, Toxicology and Pharmacy, University of Veterinary Medicine Hannover, Foundation, Bünteweg 17, 30559, Hannover, Germany. franziska.richter@tiho-hannover.de.
Stanojlovic M; Center for Systems Neuroscience Hannover, Hannover, Germany. franziska.richter@tiho-hannover.de.
Käufer C; Department of Pharmacology, Toxicology and Pharmacy, University of Veterinary Medicine Hannover, Foundation, Bünteweg 17, 30559, Hannover, Germany.
Gericke B; Department of Pharmacology, Toxicology and Pharmacy, University of Veterinary Medicine Hannover, Foundation, Bünteweg 17, 30559, Hannover, Germany.
Feja M; Department of Pharmacology, Toxicology and Pharmacy, University of Veterinary Medicine Hannover, Foundation, Bünteweg 17, 30559, Hannover, Germany.

Neurotherapeutics ; 20(1): 97-116, 2023 01.

Article em En | MEDLINE | ID: mdl-36715870

Assuntos

Doença de Parkinson; Camundongos; Humanos; Animais; Doença de Parkinson/tratamento farmacológico; Doença de Parkinson/genética; Doença de Parkinson/metabolismo; alfa-Sinucleína/genética; alfa-Sinucleína/metabolismo; Camundongos Transgênicos; Encéfalo/metabolismo; Modelos Animais de Doenças

Palavras-chave

Alpha-synuclein; Neuroprotection; Parkinson's disease; Progressive; Therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google